Davis Sherman and Walter Calvert spoke at Johns Hopkins University on February 27, 2009 about issues arising when government- and industry-financed research is conducted in labs financed with tax-exempt bonds. The audience included research contract administrators from the schools of medicine, public health, engineering and arts and sciences, as well as JHU finance staff responsible for tax-exempt finance.
Related Insights
Longer Holds, Hidden Value: Five IP Questions Private Equity Sponsors Should Ask
October 26 - 28, 2026Chicago, IL
- University of Chicago Law School
Skinny Labels and Beyond: How the Same Pharmaceutical Patent Can Yield Different Outcomes — And What Recent International High Court Rulings Mean for Your Global Strategy